Retinal Neurodegeneration in Wilson's Disease Revealed by Spectral Domain Optical Coherence Tomography

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Albrecht, Philipp ^a   Müller, Ann Kristin ^a   Ringelstein, Marius ^a   Finis, David ^a   Geerling, Gerd ^a   Cohn, Eva ^a   Aktas, Orhan ^a   Hartung, Hans Peter ^a   Hefter, Harald ^a   Methner, Axel ^a  

^a Department of Orthopedic Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER;

ADULT; AGE DISTRIBUTION; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LATENT PERIOD; MALE; RETINA BIPOLAR GANGLION CELL; RETINA DEGENERATION; RETINA FOVEA; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; SEX DIFFERENCE; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; THICKNESS; VISUAL SYSTEM PARAMETERS; WILSON DISEASE;

ADULT; CASE-CONTROL STUDIES; EVOKED POTENTIALS, VISUAL; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; RETINA; RETINAL DEGENERATION; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84869211593     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049825     Document Type: Article

References (38)

1. Bearn AG, (1953) Genetic and biochemical aspects of Wilson's disease. Am J Med 15: 442-449.
2. Cumings JN, (1948) The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain 71: 410-415.
3. de Bie P, Muller P, Wijmenga C, Klomp LW, (2007) Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet 44: 673-688.
4. Das SK, Ray K, (2006) Wilson's disease: an update. Nat Clin Pract Neurol 2: 482-493.
5. Mufti AR, Burstein E, Csomos RA, Graf PC, Wilkinson JC, et al. (2006) XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mol Cell 21: 775-785.
6. Riordan SM, Williams R, (2001) The Wilson's disease gene and phenotypic diversity. J Hepatol 34: 165-171.
7. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML, (2007) Wilson's disease. Lancet 369: 397-408.
8. Singh P, Ahluwalia A, Saggar K, Grewal CS, (2011) Wilson's disease: MRI features. J Pediatr Neurosci 6: 27-28.
9. Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, et al. (2006) Wilson's disease: cranial MRI observations and clinical correlation. Neuroradiology 48: 613-621.
10. Arendt G, Hefter H, Stremmel W, Strohmeyer G, (1994) The diagnostic value of multi-modality evoked potentials in Wilson's disease. Electromyogr Clin Neurophysiol 34: 137-148.
11. Das M, Misra UK, Kalita J, (2007) A study of clinical, MRI and multimodality evoked potentials in neurologic Wilson disease. Eur J Neurol 14: 498-504.
12. Satishchandra P, Ravishankar Naik K, (2000) Visual pathway abnormalities Wilson's disease: an electrophysiological study using electroretinography and visual evoked potentials. J Neurol Sci 176: 13-20.
13. Topcu M, Topcuoglu MA, Kose G, Nurlu G, Turanli G, (2002) Evoked potentials in children with Wilson's disease. Brain Dev 24: 276-280.
14. Ilic TV, Svetl M, Petkovic S, Kostic VS, (2005) [Multimodal evoked potential abnormalities in patients with Wilson's disease]. Srp Arh Celok Lek 133: 331-337.
15. Hsu YS, Chang YC, Lee WT, Ni YH, Hsu HY, et al. (2003) The diagnostic value of sensory evoked potentials in pediatric Wilson disease. Pediatr Neurol 29: 42-45.
16. Satishchandra P, Swamy HS, (1989) Visual and brain stem auditory evoked responses in Wilson's disease. Acta Neurol Scand 79: 108-113.
17. Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, et al. (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134: 518-533.
18. Albrecht P, Ringelstein M, Mueller A, Keser N, Dietlein T, et al. (2012) Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler. 2012 Oct;18(10): 1422-9. Epub 2012 Mar 2.
19. Brandt AU, Zimmermann H, Kaufhold F, Promesberger J, Schippling S, et al. (2012) Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS. PLoS One 7: e38741.
20. Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, et al. (2012) Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes. PLoS One 7: e36847.
21. Seigo MA, Sotirchos ES, Newsome S, Babiarz A, Eckstein C, et al. (2012) In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol.
22. Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, et al. (2012) Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 135: 521-533.
23. Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, et al. (2012) Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 119: 1250-1257.
24. Warner CV, Syc SB, Stankiewicz AM, Hiremath G, Farrell SK, et al. (2011) The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One 6: e22947.
25. Galetta KM, Calabresi PA, Frohman EM, Balcer LJ, (2011) Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics 8: 117-132.
26. Hefter H, Arendt G, Stremmel W, Freund HJ, (1993) Motor impairment in Wilson's disease, I: Slowness of voluntary limb movements. Acta Neurol Scand 87: 133-147.
27. Roberts EA, Schilsky ML, (2008) Diagnosis and treatment of Wilson disease: an update. Hepatology 47: 2089-2111.
28. Nassif N, Cense B, Park BH, Yun SH, Chen TC, et al. (2004) In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett 29: 480-482.
29. Tewarie P, Balk L, Costello F, Green A, Martin R, et al. (2012) The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One 7: e34823.
30. Albrecht P, Muller AK, Sudmeyer M, Ferrea S, Ringelstein M, et al. (2012) Optical coherence tomography in parkinsonian syndromes. PLoS One 7: e34891.
31. Klistorner A, Arvind H, Nguyen T, Garrick R, Paine M, et al. (2009) Multifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship. Doc Ophthalmol 118: 129-137.
32. Jindahra P, Petrie A, Plant GT, (2009) Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 132: 628-634.
33. Mehta JS, Plant GT, (2005) Optical coherence tomography (OCT) findings in congenital/long-standing homonymous hemianopia. Am J Ophthalmol 140: 727-729.
34. Dingle J, Havener WH, (1978) Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy. Ann Ophthalmol 10: 1227-1230.
35. Song WK, Lee SC, Lee ES, Kim CY, Kim SS, (2010) Macular thickness variations with sex, age, and axial length in healthy subjects: a spectral domain-optical coherence tomography study. Invest Ophthalmol Vis Sci 51: 3913-3918.
36. Wagner-Schuman M, Dubis AM, Nordgren RN, Lei Y, Odell D, et al. (2011) Race- and sex-related differences in retinal thickness and foveal pit morphology. Invest Ophthalmol Vis Sci 52: 625-634.
37. Wexler A, Sand T, Elsas TB, (2010) Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study. BMC Ophthalmol 10: 13.
38. Yang Q, Reisman CA, Chan K, Ramachandran R, Raza A, et al. (2011) Automated segmentation of outer retinal layers in macular OCT images of patients with retinitis pigmentosa. Biomed Opt Express 2: 2493-2503.